ArticleMedicine2020

Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report.

Claudio Cerchione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.